Copyright: ©Author(s) 2026.
World J Diabetes. Nov 15, 2026; 17(11): 125494
Published online Nov 15, 2026. doi: 10.4239/wjd.125494
Published online Nov 15, 2026. doi: 10.4239/wjd.125494
Table 1 Main advantages, disadvantages, and clinical uses of tests for prediabetes screening and diagnosis
| Test | Advantages | Disadvantages | Main purpose |
| OGTT | Reference standard for diagnosing IGT; detects post-load dysglycemia[1,117] | Time-consuming; requires fasting and at least 2 h of testing; multiple blood samples; affected by recent diet, acute illness, stress, and medications | Diagnose IGT; assess glucose tolerance; clarify borderline or inconclusive cases |
| FPG | Simple, inexpensive, widely available; requires only one blood sample[1,117] | May miss isolated IGT or post-load hyperglycemia; affected by short-term physiological variation, acute illness, and stress | Diagnose IFG; initial screening in routine practice |
| HbA1c | No fasting or timed glucose loading required; reflects glycemic exposure over past 2-3 month; relatively low short-term variability[1,23,24] | Affected by altered red cell turnover, hemoglobin variants, anemia, blood loss, kidney disease, pregnancy, HIV, and some medications | Screening and diagnosis according to specific guidelines; risk stratification and follow-up monitoring |
| CGM | Provides continuous glucose profiles; captures glycemic variability and postprandial excursions; avoids repeated venipuncture[27,28] | High cost and limited access; sensor-related discomfort; interstitial glucose may lag behind blood glucose; diagnostic thresholds for prediabetes are not standardized[28] | Mainly used in diabetes management; may be useful for research or selected high-risk individuals, but not routine prediabetes diagnosis |
- Citation: Shi DN, Jia F, Wang ZR, Wang Y, Xi YR, Wang X, Li WF. Prediabetes: Epidemiology, diagnosis, and management. World J Diabetes 2026; 17(11): 125494
- URL: https://www.wjgnet.com/1948-9358/full/v17/i11/125494.htm
- DOI: https://dx.doi.org/10.4239/wjd.125494